Clinical Trial Update: A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of KH607 tablets for postpartum depression; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Depression

Drugs mentioned

• KH607

Snippet

Sponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd. | Conditions: Postpartum Depressive Disorder | Phase 2 | Status: NOT_YET_RECRUITING